Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-met

International Journal of Oncology

Volumn 33, Issue 4, 2008, Pages 697-703

  Onimaru, Y ^a   Tsukasaki, Kunihiro ^a   Murata, K ^b   Imaizumi, Y ^a   Choi, Y L ^c   Hasegawa, H ^a   Sugahara, K ^a   Yamada, Y ^a   Hayashi, T ^d   Nakashima, M ^a   Taguchi, T ^a   Mano, H ^c   Kamihira, S ^a   Tomonaga, M ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adult T cell leukemia lymphoma; Autocine paracrine; c Met; Hepatocyte growth factor; Human T lymphotropic virus type I

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 6; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ACUTE LEUKEMIA; ARTICLE; AUTOCRINE EFFECT; AUTOPHOSPHORYLATION; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CELL INFILTRATION; CELL PROLIFERATION; CHRONIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; STROMA CELL; SUPERNATANT; T CELL LEUKEMIA; T CELL LYMPHOMA;

APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CYTOKINES; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-6; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; TIME FACTORS;

EID: 54049147745     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000055     Document Type: Article

References (37)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K and Uchino H: Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492, 1977.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419, 1980.
3. Taylor GP and Matsuoka M: Natural history of adult T-cell leukemia/ lymphoma and approaches to therapy. Oncogene 24: 6047-6057, 2005.
4. Shimoyama M: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-1987). Br J Haematol 79: 428-437, 1991.
5. Shimoyama M: Chemotherapy of ATL. In: Adult T-Cell Leukemia. Takatsuki K (ed). Oxford University Press, Oxford, pp221-237, 1994.
6. Pawson R, Mufti GJ and Pagliuca A: Management of adult T-cell leukaemia/ lymphoma. Br J Haematol 100: 453-458, 1998.
7. Tsukasaki K, Utsunomiya A, Fukuda H, et al: VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25: 5458-5464, 2007.
8. Boros P and Miller CM: Hepatocyte growth factor: a multi-functional cytokine. Lancet 345: 293-295, 1995.
9. Furge KA, Zhang YW and Vande Woude GF: Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 19: 5582-5589, 2000.
10. Boccaccio C and Comoglio PM: Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 6: 637-645, 2006.
11. Peruzzi B and Bottaro DP: Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 12: 3657-3660, 2006.
12. Beilmann M, Vande Woude GF and Dienes HP and Schirmacher P: Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 95: 3964-3969, 2000.
13. Borset M, Hjorth-Hansen H, Seidel C, Sundan A and Waage A: Hepatocyte growth factor and its receptor c-met in multiple myeloma. Blood 88: 3998-4004, 1996.
14. Capello D, Gaidano G, Gallicchio M, et al: The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. Leukemia 14: 285-291, 2000.
15. Yamada Y, Kamihira S, Murata K, et al: Frequent hepatic involvement in adult T cell leukemia: comparison with non-Hodgkin's lymphoma. Leuk Lymphoma 26: 327-335, 1997.
16. Imaizumi Y, Murota H, Kanda S, et al: Expression of the c-Met proto-oncogene and its possible involvement in liver invasion in adult T-cell leukemia. Clin Cancer Res 9: 181-187, 2003.
17. Choi YL, Tsukasaki K, O'neill MC, et al: A genomic analysis of adult T-cell leukemia. Oncogene 47: 2163-2173, 2006.
18. Masuya D, Huang C, Liu D, et al: The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients. Br J Cancer 90: 1555-1562, 2004.
19. Khan KN, Masuzaki H, Fujishita A, et al: Interleukin-6- and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis. Hum Reprod 20: 2715-2723, 2005.
20. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG and Comoglio PM: The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49: 323-328, 1991.
21. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y and Nakamura T: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57: 3305-3313, 1997.
22. Mazzone M and Comoglio PM: The Met pathway: master switch and drug target in cancer progression. FASEB J 20: 1611-1621, 2006.
23. Matsumoto K and Nakamura T: Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 119: 477-483, 2006.
24. Yamamura M, Yamada Y, Momita S, Kamihira S and Tomonaga M: Circulating interleukin-6 levels are elevated in adult T-cell leukaemia/lymphoma patients and correlate with adverse clinical features and survival. Br J Haematol 100: 129-134, 1998.
25. Yamada Y, Ohmoto Y, Hata T, et al: Features of the cytokines secreted by adult T-cell leukemia (ATL) cells. Leuk Lymphoma 21: 443-447, 1996.
26. Tendler CL, Greenberg SJ, Burton JD, et al: Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 46: 302-311, 1991.
27. Yamano Y, Machigashira K, Ijichi S, Usuku K, Kawabata M, Arimura K and Osame M: Alteration of cytokine levels by fosfomycin and prednisolone in spontaneous proliferation of cultured lymphocytes from patients with HTLV-I-associated myelopathy (HAM/TSP). J Neurol Sci 151: 163-167, 1997.
28. Gasparini G, Longo R, Fanelli M and Teicher BA: Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions. J Clin Oncol 23: 1295-1311, 2005.
29. Migone TS, Lin JX, Cereseto A, et al: Constitutively activated Jak-STAT pathway in T-cells transformed with HTLV-I. Science 269: 79-81, 1995.
30. Danilkovitch-Miagkova A and Zbar B: Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J Clin Invest 109: 863-867, 2002.
31. Kukita T and Arima N: Autocrine and/or paracrine growth of adult T-cell leukaemia tumour cells by interleukin 15. Br J Haematol 119: 467-474, 2002.
32. Yamada Y, Tsukasaki K, Kamihira S, et al: Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor alpha on ATL cells. Blood 91: 4265-4272, 1998.
33. Ruckes T, Saul D, Van Snick J, Hermine O and Grassmann R: Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood 98: 1150-1159, 2001.
34. Waldmann TA, Goldman CK, Bongiovanni KF, et al: Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2. Blood 72: 1805-1816, 1988.
35. Mori N, Yamada Y, Ikeda S, et al: Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100: 1828-1834, 2002.
36. Zhang Z, Zhang M, Goldman CK, Ravetch JV and Waldmann TA: Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H. Cancer Res 63: 6453-6457, 2003.
37. Mori N, Matsuda T, Tadano M, et al: Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. J Virol 78: 4582-4590, 2004.